Author

Catherine S. Bettington

Observed names: C. Bettington, Catherine Bettington, Catherine S Bettington

Institutions: The University of Queensland, Royal Brisbane and Women's Hospital

Observed institutions: Queensland Health, Mater Health Services, The University of Queensland, Royal Brisbane and Women's Hospital

ORCID: 0000-0002-8227-6320

Observed ORCID: 0000-0002-8227-6320

OpenAlex ID: A5048420012

Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)

2021 · Shankar Siva, Mathias Bressel, et al. · JAMA Oncology · 90

PDF

Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis

2018 · Mihir Shanker, Benjamin Chua, et al. · Neuro-Oncology Practice · 40

Emerging understanding of dosimetric factors impacting on dysphagia and nutrition following radiotherapy for oropharyngeal cancer

2012 · Bena Cartmill, Petrea Cornwell, et al. · Head & Neck · 32

Non‐small cell lung cancer brain metastasis screening in the era of positron emission tomography‐ CT staging: Current practice and outcomes

2018 · Mauricio E Diaz, Maciej Debowski, et al. · Journal of Medical Imaging and Radiation Oncology · 30

PDF

Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases

2023 · Shankar Siva, Pitchaya Sakyanun, et al. · Journal of Clinical Oncology · 25

PDF

A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer

2013 · Catherine S Bettington, Lee Tripcony, et al. · Journal of Medical Imaging and Radiation Oncology · 17

The safety, feasibility, and efficacy of an 18-week exercise intervention for adults with primary brain cancer – the BRACE study

2023 · Carolina X. Sandler, Gabrielle C. Gildea, et al. · Disability and Rehabilitation · 10

PDF

Impact of radiopacified bone cement on radiotherapy dose calculation

2020 · Scott B. Crowe, Jane Bennett, et al. · Physics and Imaging in Radiation Oncology · 9

PDF

[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program

2024 · Nathaniel Barry, Eng-Siew Koh, et al. · Physics and Imaging in Radiation Oncology · 5

PDF

Commissioning Tests of Radixact Synchrony Using Patient-Specific 3D-Printed Lung Phantom Inserts

2025 · Sharon R Gordon, Scott B Crowe, et al. · Cureus · 4

PDF

Biopsy decision for intermediate–high-risk lung nodules is significantly changed when guided by prior positron emission tomography/CT (PET/CT) results: results of the prospective PET-FIRST study

2025 · David Fielding, Calvin Sidhu, et al. · BMJ Open Respiratory Research · 2

PDF

Exposure to thoracic radiation and the risk of cancer

2022 · Catherine Bettington, Philip Chan, et al. · European Respiratory Society eBooks · 2

Evaluating Radixact Synchrony Tracking Accuracy in Response to Anatomical Changes During Radiotherapy Using 3D Printed Lung Inserts

2026 · Sharon R. Gordon, Scott B. Crowe, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · 1

Processing Real-Time Target Tracking and Adaptation Data from the Radixact Synchrony System

2026 · Scott B. Crowe, Jemma Walsh, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · 1

OC-0610 Long-term outcomes of TROG13.01 SAFRON II: Single vs multi-fraction SABR for oligometastases to lung

2023 · S. Siva, P. Sakyanun, et al. · Radiotherapy and Oncology · 1

Characterization of Anatomical Variations in the Central Nervous System to Improve Safety and Precision of Radiotherapy

2026 · T. Kairn, C. Bettington, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany

1059P Consolidation thoracic radiotherapy with chemo-immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC):CHEST-RT (TROG 20.01) trial

2025 · E. Hau, H. Gee, et al. · Annals of Oncology

Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial – protocol for a phase II study

2025 · Sagun Parakh, Harriet Gee, et al. · BMJ Open

Spontaneous regression of squamous cell carcinoma of the lung with high PD-L1 expression: A case report and literature review

2023 · Kelleher Retchford, Catherine Bettington, et al. · Journal of Case Reports and Images in Oncology

PDF

PD-0648 FET-PET incorporation for GBM radiotherapy planning: multi-site FIG Study credentialling programme